Composition
- Active ingredients
- DASABUVIR SODIUM EQ 250MG BASE; OMBITASVIR, PARITAPREVIR, RITONAVIR 12.5MG, 75MG, 50MG
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA206619.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Viekira Pak (Copackaged)
- Active substance
- dasabuvir sodium
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Abbvie
- Status
- Discontinued
- FDA approval
- 19 Dec 2014
- Application
- NDA206619-001